Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity |
---|---|
6/30/2025 | $ 38.88M |
3/31/2025 | $ 44.13M |
12/31/2024 | $ 52.09M |
9/30/2024 | $ 63.54M |
6/30/2024 | $ 74.87M |
3/31/2024 | $ 83.37M |
12/31/2023 | $ 88.73M |
9/30/2023 | $ 11.51M |
6/30/2023 | $ 17.27M |
3/31/2023 | $ 26.43M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Sep 30, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.47K |
---|---|
min | $ -1.4B |
max | $ 2.14B |
average | $ 385.07M |
median | $ 167.44M |
std | $ 549.23M |